MYXOID LIPOSARCOMA

Clinical trials for MYXOID LIPOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new MYXOID LIPOSARCOMA trials appear

Sign up with your email to follow new studies for MYXOID LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2

New shot aims to reawaken Cancer-Fighting cells

Disease control Not yet recruiting

This early safety study tests an immunotherapy drug called N-803 in patients with two rare types of soft tissue sarcoma. The participants have already been treated with a personalized cell therapy, but their cancer has started to grow again. Researchers want to see if N-803 can s…

Matched conditions: MYXOID LIPOSARCOMA

Phase: EARLY_PHASE1 • Sponsor: Northwestern University • Aim: Disease control

Last updated Apr 01, 2026 21:56 UTC

MYXOID LIPOSARCOMA

Get alerted when new MYXOID LIPOSARCOMA trials appear

New shot aims to reawaken Cancer-Fighting cells